MGMT and glioma: Recently, Chung et al. [118] fabricated PEI-coated iron oxide nanoparticles to deliver O6-methylguanine-DNA methyltransferase (MGMT)-targeting siRNA to glioma cells for inhibiting MGMT activity and subsequent reduction of resistance to chemotherapy agents such as Temozolomide (TMZ).